Chemokine-directed immune cell infiltration in acute and chronic liver disease.
about
Inflammatory status in human hepatic cirrhosisReview article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitisInterference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injuryHuman amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.The chemokine CCL3 promotes experimental liver fibrosis in mice.Natural killer T (NKT) cells in autoimmune hepatitisFunctional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosisInterleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cellsTNFα-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infection.Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.The expression of HIV-1 Vpu in monocytes causes increased secretion of TGF-β that activates profibrogenic genes in hepatic stellate cells.Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis.Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice.Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.Functional role of monocytes and macrophages for the inflammatory response in acute liver injury.A deleterious role for Th9/IL-9 in hepatic fibrogenesis.A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in miceShort-term exercise training improves insulin sensitivity but does not inhibit inflammatory pathways in immune cells from insulin-resistant subjects.Focus on: Alcohol and the liver.DJ-1 deficiency attenuates expansion of liver progenitor cells through modulating the inflammatory and fibrogenic nichesChemokines and their receptors: orchestrating a fine balance between health and disease.Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.Update on the pathophysiology of liver fibrosis.Innate immune responses in hepatitis B virus (HBV) infection.Young adult binge drinkers have immunophenotypic changes in peripheral polymorphonuclear cells and monocytes.The role of macrophages in obesity-driven chronic liver disease.Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver.Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors.Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.Toll-like receptor-2 exacerbates murine acute viral hepatitis.Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B.The role of chemokines in acute liver injury.TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model.Identification of Pathways in Liver Repair Potentially Targeted by Secretory Proteins from Human Mesenchymal Stem Cells.Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine productionCXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis.RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
P2860
Q26778040-3A105405-5C79-4117-8BA6-5FF9756683EFQ26827599-0ECD2DA5-1A82-4633-B9CC-F28535950709Q28730116-05EC945C-5AA8-40DD-A637-205E4E5F5F77Q31066154-8520C3DE-3819-4490-ADA4-6C5EA8E9EACEQ31120713-86A94C55-6B40-4629-BD8F-A487EBBECB27Q33580295-CDCD5711-F986-40A7-9372-AC0FDCD9BDF3Q33604746-A995A21C-F364-4381-B932-4C2F99FC69D0Q33952373-A15BF195-AA48-4DFE-9143-119BEB2A8519Q34384443-0645983B-C116-4167-85F3-411C40EB3014Q34539801-BC2ED6A2-6BCA-4E42-AD35-BF89C033232FQ35045751-D625C2F3-3E08-405B-B6BE-0573ED1E1115Q35097640-2C6A05C6-E50E-4A91-9A31-404B36F62493Q35874927-1951438F-6717-42A9-88E6-E7F6CC329B06Q35944978-EE8F26F5-67AF-4F7C-B6A8-B4FAA255991BQ35995449-4EEAFFB4-C34F-4744-8084-14E8B97316F7Q36129129-8051E72F-FB60-4262-8F27-C5F8A2CE5892Q36331567-217016CC-1832-46B1-A8BC-D89FA898BC86Q36428081-08F4F8F4-8854-4B97-BC9E-20E27A52B256Q36823274-5BEA27D2-A76B-4F9D-92F4-EB01CB83B586Q36825685-8FC5F12B-1BCB-43D7-89BA-000CF656AF89Q37386702-B967BF86-2C32-47C8-86E6-FA4B1DF40F70Q37482781-CED57240-55AB-4735-86BD-65440E58B6C5Q37603336-F15692AC-88D1-4BE6-992D-F83C8FAC7D2BQ37671303-64D7E930-EB6E-4794-8022-75C4814CDDAEQ37777155-1E367229-964D-4972-BEDD-B634D7E697B9Q38186180-746ED0CD-2D1B-4ABD-8CF6-91C6CD106553Q38686560-A569A75F-87EF-48C6-919C-F34FFE24AE14Q38758810-184D2EFF-C688-485C-9781-1E45A916D93CQ39064350-2317ED38-AFF2-4CB0-9F24-3C39E43A15EBQ39469014-CAEF0488-9109-4A62-B5D1-2AA0191DC590Q39639458-13F08734-E122-49E8-B143-48C22055C623Q40641510-048BC0C7-9F8E-47A3-B444-29F5C27713EFQ40919115-C7CA6AEC-66FC-4991-8495-1DF9C3DB817EQ42208932-69305A91-4CBD-4AAE-BB30-A423EE4D17C2Q42259539-0BB4D2FA-C176-403E-A1E8-774A57A6F889Q42397309-46EAD675-FA2A-410B-A859-5CB3161276C6Q42450600-650E3473-2409-4013-A423-6678BD14901FQ43159403-44881EB7-A1D0-4ECA-BC8E-993229EC06AFQ43809862-D1F827A3-85F0-486B-8CDC-0A26633DC747Q44131130-4CBC97F7-A673-4A33-A003-1007902A42E0
P2860
Chemokine-directed immune cell infiltration in acute and chronic liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemokine-directed immune cell infiltration in acute and chronic liver disease.
@en
Chemokine-directed immune cell infiltration in acute and chronic liver disease.
@nl
type
label
Chemokine-directed immune cell infiltration in acute and chronic liver disease.
@en
Chemokine-directed immune cell infiltration in acute and chronic liver disease.
@nl
prefLabel
Chemokine-directed immune cell infiltration in acute and chronic liver disease.
@en
Chemokine-directed immune cell infiltration in acute and chronic liver disease.
@nl
P2093
P2860
P356
P1476
Chemokine-directed immune cell infiltration in acute and chronic liver disease.
@en
P2093
Christian Trautwein
Frank Tacke
Hermann E Wasmuth
Karlin Raja Karlmark
P2860
P304
P356
10.1586/17474124.2.2.233
P577
2008-04-01T00:00:00Z